Discover how specific mutations in ARS genes cause inherited peripheral neuropathies and potential avenues for targeted ...
Morning Overview on MSN
Gene therapy targets rare cystic fibrosis mutation affecting ~10%
For roughly one in ten people living with cystic fibrosis, the drugs that have transformed survival for most CF patients are ...
A study by IRB Barcelona reveals that transfer RNA (tRNA) genes accumulate mutations at a frequency up to nine times higher ...
The gene editing treatment targets the relatively common 1717-1G>A splicing mutation, which does not respond to many current CF therapies.
Scientists have used prime editing to permanently correct nonsense mutations in the CFTR gene, which cause cystic fibrosis in about 10% of patients who do not benefit from existing drugs. The method ...
Cells manufacture proteins by following instructions encoded in messenger RNA, which is read in three-letter groups called ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results